Table 1 Comparison of 1st and multiple IV lignocaine treatment groups
From: Efficacy and adverse effects of intravenous lignocaine therapy in fibromyalgia syndrome
1st time IV lignocaine treatment | multiple IV lignocaine treatments | statistical analysis | |
|---|---|---|---|
Number | 13 | 37 | |
age (mean, SD) | 54.3(4.0) | 49.6(10.7) | t(44) = -0.93, NS |
sex (f:m) | 12:1 | 28:9 | χ2 (1, N = 50) = 0.10, NS |
Duration of FMS, yrs, mean (SD) | 5.7(5.3) | 6.8(4.3) | t(42) = -0.11, NS |
pre-treatment hrs in pain (mean, SD) | 23.0(2.2) | 21.8(4.5) | t(42) = -0.83, NS |
co-morbidity | 5 | 9 | χ2 (1, N = 50) = 2.87, NS |